843
KLINICKÁ341804301074588109168189242288347
FARMAKOLOGIE708804301074392139212266313373416475534555599
A13288043010753
FARMACIE1402804301074292139211266317337381
/18048043010757
Klin1880804301077091109157
Farmakol2057804301074278105179220258305325
Farm2402804301074178104179
2019;2601804301074386126164180
33(3):2801804301074385107150171185
37–403006804301074484125172217
/32438043010757
www.klinickafarmakologie.cz4568804301076513320121425327329234035839843647950254457164568672477179183988990895196610061045
401828026012657116
PŘEHLEDOVÉ341207012660124182256312369444520587645
ČLÁNKY1008207012660115187259327395
Budoucí34136501063475114155197231249
trendy6053650106306698140179215
v835365010636
léčbě8863650106306297133165
karcinomu106736501063476111146163204245299339
jícnu14213650106234175117157
(prevence,15933650106245792124164196237272304321
biologická19293650106345292124163203220255291333
terapie,22763650106316399141175193224241
imunoterapie,253136501061670111152193223255291333368385416433
individualizovaná29783650106175897115153171210251289320338371410447484525565
terapie,35573650106316399141175193224241
novinky381336501063980117135176211250
v4079365010636
chirurgii)41313650106337491127168203242260277300
7.3405530853645
Morris4015540835493114136152178
CD,595554083408596
Armstrong7075540834163121148171192229268307
GR,1030554083448094
Bigley1140554083355189105140171
G,13275540834457
Green1401554083436599134172
H,15905540834457
Attwood1663554083416286139177216255
SE.1934554083336578
Cyclooxygenase-23406540834169102118157196228262302337377410437473497529
expression8856540834072112135170197225240279319
in12206540832059
the12956540832766102
Barrett's1413654083417597120155178203217244
metaplasia-dysplasia-adenocarcinoma167365408358941171511912082412682833164294966084429496610442949661124294966126429496615842949661674294966197429496622042949662324294966263429496628342949663144294966352429496638542949664234294966460429496649242949665244294966544429496657542949665904294966628429496666542949667234294966755
sequence.11476540832964103141175213245279291
Am14566540834199
J157065408327
Gastroenterol.16156540834477103126148185220258280313334372388400
2001;3408540833468104136144
96(4):500854083346988121139151
990–996.6668540833469105143178213248262
8.3409530853652
Shirvani407954083377590111146179217232
VN,654954083408699
Ouatu-Lascar7729540834786118140178200233267293325358379
R,11679540833953
Kaur12369540833972110131
BS,1382954083407285
Omary148695408347106138159193
MB,16999540835490103
Triadafilopoulos1817954083375470102141173340105408317344987127166204219257284
G.64210540834458
Cyclooxygenase7181054083406799114152191221255294328367399425460
21194105408337
expression124610540833768108129164190217232270308
in157010540831755
Barrett's16401054083387192114148171195209235
esophagus1890105408334619934011540833977109148186212
and56511540833169108
adenocarcinoma:68611540833271106144182214247268299314352390448480493
Ex119211540833265
vivo12691154083324880118
induction14021154083125089126158182198235274
by168911540833869
bile17711154083395470104
salts1888115408326597597125
and34012540833270109
acid4621254083326479118
exposure.59412540833465105143170207229263275
Gastroenterology.88212540834477103126148185221259280314335372388426466498508
2000;140312540833569105141154
118(3):15701254083346293112146163175
487–496.175812540833470103136173206241254
9.34013530853650
Singh4051354083385391131169
S,58913540833851
Singh6561354083385291130168
AG,84013540834689103
Singh9581354083385391131169
PP,11421354083417681
Murad124313540835593115148187
MH,1451135408355100113
Iyer15791354083205287108
PG.17031354083408599
Statins18181354083385992114130168194
are3401454083325387
associated4421454083336086125157173205226260300
with7581454083516689127
reduced9001454083225696133165199239
risk1154145408322386494
of126414540833757
esophageal13371454083346199139177210249284315331
cancer,168314540833366104136169191200
particularly190014540833972933401554083223770108123156177193225
in58115540832058
patients65415540834478100115150189210238
with9131554083516789128
Barrett's10561554083417496118152175199213240
esophagus:131115540833562100140179212251289316328
a1655155408337
systematic17081554083265986110144202235257272304
review3401654083215587103137189
and54416540833674113
metaanalysis.67716540835893115148180218251266298325340366379
Clin10721654083445974112
Gastroenterol120416540834477103126148185220259280314335372388
Hepatol.161216540834479119152173210226239
2013;186616540833973105135146
11(6):3401754083346277110128140
620–629.49517540833568102140177211245256
10.3401853085367187
Ganz44418540835084123154
RA,61518540834186101
Peters73318540834176100135157186
JH,9361854083307690
Horgan104318540835090113152186225
S,128518540833953
Bemelman135418540834278138174191250284323
WA,170018540835798113
Dunst183018540835191130158183
CM,34019540834199114
Edmundowicz47219540834081141182222264305358376410443
SA,93319540834083100
Lipham10501954083395698139174235
JC,13021954083317590
Luketich140919540833979111148172190224265
JD,16911954083318093
Melvin180819540835693111146164204
WS,34020540835792106
Oelschlager46820540834784101129162202218252292329351
BK,8362054083417894
Schlack-Haerer94720540833871111128161195226248295329365388423446
SC,14102054083388094
Smith152120540833897113137177
CD,171420540834692105
Smith183620540833796113137176
CC,3402154083407994
Dunn45421540834585124164
D,63721540834658
Taiganides7122154083356581122155195211251288316
PA.10452154083387793
Esophageal115421540833665105146186219260296329346
sphincter151721540832970109126165199224259282
device181621540834177111128161197
for3402254083185780
gastroesophageal43722540834377105129152191228256295336376410450487520537
reflux9912254083256081100139172
disease.11802254083425986123156184220234
N1435225408345
Engl149722540833776117133
J1647225408329
Med.169722540835591132147
2013;186122540833874107138151
368(8):34023540833470107127162182195
719–727.55223540833569101140173209243250
11.3402453085366678
Zadeh43724540833871110145183
J,63524540832840
Andreoni69324540834179118139173212251266
A,97724540834155
Treitl10482454083355287102124140
D,120624540834556
Ben-David127824540833873111134181213245260299
1.159324540833746
Spotlight165524540833574113135150165204242264
on193724540833776
the3402554083226095
Linx™4502554083345088119160
Reflux6262554083387390107145176
Management82125540835486125157196231289324362383
System12202554083356592115149207
for14422554083215981
the15382554083256398
treatment16512554083254680112134192227265287
of195625540833756
gastroesophageal3402654083386995117138174209235273311349380419453484499
reflux853265408318516885122152
disease:10172654083385278112143169203215
evidence12442654083336580118152189221253
and151026540833168106
research.16312654083185177111142163193230243
Med188626540835488126
Devices34027540834581113129161194221
(Auckl).5762754083196097129160176195206
2018;79827540833468100131143
11:9562754083346271
291–300.104227540833468100133166200236249
12.3402853085366884
Inoue4392854083155392130165
H,61928540834457
Ito6922854083153774
H,78128540834557
Ikeda8542854083154579118151
H,102028540834457
Sato10932854083326587124
C,123328540834053
Sato13012854083336687124
H,144128540834457
Phalanusitthepha151328540833673105121153191228255270292316354389429467500
C1,3402954083407281
Hayee44029540834476107141177
B2,6322954083397385
Eleftheriadis7322954083375287106131169204225241273312327353
N1,11042954083457685
Kudo120529540833875114153
SE3.137329540833668104116
Anti-reflux150829540834179101116139161195212229267298
mucosectomy1825295408357951271643403054083266194118155213244
for5993054083226082
gastroesophageal69630540834274101124145182218245283323361393432467499515
reflux1226305408324587693130162
disease14033054083425783118150177212
in163030540831856
the17023054083256398
absence18163054083357410113617434031540833166
of42131540834362
hiatus4993154083435891113151178
hernia:69231540834379100139154187199
a907315408337
pilot9603154083395570109131
study.11063154083325594133165176
Ann129731540834785124
Gastroenterol.144131540834477104128150187223262284318339377393406
2014;186331540833974106137149
27(4):3403254083346784116134146
346–351.50132540833470106144176209240249
13.3403353085356781
Inoue4363354083124987124158
H,60633540834456
Sumi67433540833269126140
K,82633540833549
Tatsuta8873354083325981108144166198
T,109733540833241
Ikebuchi11533354083114174112150181218233
Y,139833540833543
Tuason14533354083326596122159197
J.166533540832133
Clinical17103354083405469106120152184198
Results1921335408335693403454083266378100128
of48134540833756
Antireflux55034540834179100115136170188204242273
Mucosectomy83634540835492124160187222254278315373403
(ARMS)12553454083165792148180199
for14693454083165475
Refractory15573454083357089111144176200237258292
Gerd.186234540834378100138151
Gastrointestinal34035540834476103126148185200238260293320343359397429444
Endoscopy,80035540833270109147174206243283314324
2017;113935540833468100129139
85(5):12943554083346885119137149
AB120.145835540834177109139173186
14.3403653085366985
Chan44036540834684116155
DS,6153654083467992
Campbell72236540834578137176216252267283
F,102036540833844
Edwards107936540833877128161183221248
P,134236540834145
Jasani14033654083296288122160175
B,159436540834053
Williams16683654083577489104119152210237
GT,19253654083447988
Lewis34037540833266118134160
WG.521375408358102116
Relative6533754083407692124146162195229
Prognostic8983754083406199139178216243267282315
Value12283754083417388126162
of140537540834362
Human148837540834583141174212
Epidermal17163754083387793132168189248281296
Growth34038540834467105157182221
Factor57738540833868101126163185
Receptor77838540834177111145185208245268
21061385408340
(HER2)111738540832470103140176195
Expression132738540833972112134169197224239278317
in166038540832059
Operable174038540834888125147180220237272
Oesophagogastric34039540834782109148187226258297335375407434457478494526
Cancer.88139540834073111143177198208
ISRN11053954083144782127
Surg.12483954083327091129142
2012;140539540833468100130142
2012:156339540833468100130142
804891.172139540833469105141176208217
15.2140553085366882
Van22355540833566104
Cutsem2352554083397597125159217
E,25815540833346
Kang26395540833568106144
Y,27965540833543
Chung28525540833977114152190
H,30555540834456
Sawaki31245540833265115147177193
A,33305540834154
Lordick3397554083316890127142174203
F,36135540833238
Hill367955408341567186
J,37805540832133
Lehle21406540833164101116150
M,23016540835467
Feyereislova2380654083316495128149182196221236273304336
A,27286540834053
Bang27936540833567104142
Y.29476540833443
Efficacy300165408333506785116148179211
results3227654083175076113127149176
from3417654083153773130
the3561654083195690
ToGA36636540833265109149
trial:214075408321425889104116
A226875408341
phase23237540833977108134169
III2507754083122742
study2561754083264886124156
of27297540833756
trastuzumab280075408319407298121158187224281313352
added31647540833270108143182
to33617540831855
standard3428754083264981118157189209247
chemotherapy3687754083316810321408540835796117156191212245284315
(CT)2471854083165591112
in25998540831250
first-line266285408317345582105125141156194229
human29048540833775133165203
epidermal3120854083347389128162184242274290
growth3423854083385996147172210
factor3648854083165082106143164
receptor2140954083205385118156177213233
2238595408334
(HER2)-positive2433954083165991125160177199238275301315337351383416
advanced28619540833169101132169200233271
gastric3144954083386995117137152183
cancer3339954083316399131163184
(GC).3537954083165797116127
Journal367895408321589511621401054083387085
of224110540833756
Clinical23121054083405570108123155188204
Oncology253110540834786118155171209248280
27,28271054083346772
no.29151054083377688
15_suppl.301810540833565101129166205245260273
16.21401153085367085
Wilke22461154083587489119154
H,242011540834557
Muro249811540835593114152
K,266511540834055
Van273511540834173111
Cutsem286111540834682105133168226
E,310311540833851
Oh317511540834786
SC,32761154083387992
Bodoky338311540834180119158189223
G,362611540834458
Shimada36991154083387691214012540835790129161
Y,231612540833846
Hironaka23801254083445980117156188218252
S,264712540833548
et271012540833659
al.27841254083344962
Ramucirumab286412540833568126164196211232270328360400
plus32811254083395592119
paclitaxel341712540833972104119134157190221255271
versus3703125408334688921401354083266390
placebo22461354083395487119153192231
plus24931354083385492118
paclitaxel262713540833972104120135157190221255271
in291313540831654
patients29831354083397293109143181203231
with32301354083516689127
previously33731354083396094127142180218245260292
treated3680135408323447811021401454083225595
advanced225014540833574106139177210243283
gastric25511454083387097120141157189
or275814540833759
gastro-oesophageal28351454083387097120141179202242277304342382421453492527559574
junction34241454083185694126150165203242
adenocarcinoma368114540833473108214015540833876108141162194209247285343375
(RAINBOW):25311554083175395111156192240297319331
a2875155408332
double-blind,292215540833877115154170205228268284299336376388
randomised33261554083185189129167225240266301341
phase368015540833978110214016540832661
32216165408335
trial.2266165408322435991106119
Lancet240016540833265103135169191
Oncol.260716540834785117154170183
2014;280516540833569100132143
15(11):29641654083346482113141155167
1224–1235.31471654083346498130167198228263296308
17.21401753085366876
Ruhstaller223417540833573111137161193209224259280
T,252917540833543
et258817540833558
al.26611754083344962
Neoadjuvant274017540834580118151190206243276309347368
chemotherapy312417540833371106164202224262297318351390422
followed3561175408320587489127178212252
by214018540833971
chemoradiation222718540833675111169208230264304319352374389428467
and271018540833776115
surgery28411854083327091130165187222
with30841854083516790128
and322818540833776116
without33651854083516790128167206229
cetuximab36101854083377194132164180214019540835790129
in228419540832058
patients23571954083447799114149187208236
with26131954083516689127
resectable27551954083266087122155179212251267301
esophageal307219540833966104143182214253288320335
cancer:342319540833669107139173194208
a3646195408337
randomized,36981954083215492214020540833876135150179213252265
open-label,241920540833776112150173189221260296311324
phase275620540833977110136171
III29432054083132843
trial3001205408320425789105
(SAKK31212054083174889125161
75/08).32962054083346790124160178189
Ann349820540834179117
Oncol.362920540834785118154170183
2018;214021540833468100131143
29(6):22992154083346887120138150
1386–1393.24652154083346498133171202232265298311
18.21402253085366985
Zhang224122540833876108146185
Y,244222540833543
Pan250122540833567105
T,262222540833342
Zhong268022540833775114152191
X,288722540833852
Cheng295522540833977112150189
C.316022540834054
Resistance32302254083357097112138161194232264298
to354322540832259
cetuximab36172254083326688126158173214023540835789128
in228323540831250
EGFR-overexpressing234623540833276109144165205236270291325356396417451477504518556595
esophageal29542354083336098137175208246281313328
squamous329423540832665103135192230268294
cell3601235408331648095
carcinoma3708235408331648521402454083314684122181213
xenografts236824540833165103141181202235254279307
due269124540833875110
to281724540832259
FGFR2289224540833276109144180
amplification308724540833390130145160178195227260282297335374
and347624540833270109
overexpression.36012454083387010412515919121402554083396094121148163201239252
J2408255408324
Pharmacol244725540833573105126184217249286302
Sci.2764255408333658093
2014;287225540833469100131143
126(1):30312554083346497116148162174
77–83.322125540833468101137171183
19.21402653085366982
Mellman223626540835490105120178210248
I,250026540831326
Coukos254026540834077115145183209
G,276426540834357
Dranoff283526540834567100138176196215
G.306426540834458
Cancer313626540834073111143177198
immunotherapy334926540831471129167205243265303338360393432463
comes214027540833168126161188
of234427540833756
age.241527540833271106118
Nature.25492754083447799136158192204
2011;276827540833468100128136
480(7378):291927540833571106125160194226260278290
480–489.322427540833470105143180216251262
20.21402853085367186
Razack22392854083356897130162192
AH.24432854083418599
Bacillus255428540833668100115130145182208
Calmette-Guerin27752854083407287144179201225259282328366400421437474
and326228540833269108
bladder33832854083385486125163198219
cancer.361528540833163101133166187197
Asian21402954083416984116154
J2309295408324
Surg.23482954083337091130143
2007;250629540833468104137147
30(4):26682954083346988121139151
302–309.283429540833469101136168203238249
21.21403053085367082
Bartnik22383054083356889114152168198
A,245230540834155
Nirmal25233054083456081139172187
AJ,27263054083416881
Yang282330540833564102141
S.298030540833346
Peptide304330540833568107130145184219
Vaccine32783054083356799130145183218
Therapy351230540833272107128161200231
in375930540831553
Colorectal21403154083407692129150184216240272287
Cancer.243931540834072110141174195205
Vaccines26573154083356697128143180214241
(Basel).29133154083165183109144159178189
2013;31143154083346899128139
1(1):3266315408334488094105
1–16.33843154083336696127140
Published353631540833572110126140166203238277
online21403254083377691106144179
2012233432540833468100130
Aug248032540834077117
23.26123254083346981
22.21403353085367389
Kono224533540834179118157
K,241833540834055
et248933540833962
al.25673354083375366
Multicenter,265433540835593109131147180214252274309330340
phase301033540834483116143179
II320433540832036
clinical32563354083365267106121154187203
trial3474335408328496598113
of360333540834363
cancer36813354083377010921403454083316586
vaccination22413454083326597128143181213235250288327
for25833454083185677
advanced267534540833271104137175207241280
esophageal29703454083346199139177210249284315331
cancer331634540833164102134168189
with35203454083516689127
three36623454083226081115150
peptides214035540833974113136151190225251
derived24063554083387394110142177216
from26383554083173977135
novel278835540833775107142157
cancer-testis296035540833164102134168189209231265292315331357
antigens.33313554083327092107146181219245259
Journal360535540832462100121160192207
of214036540833757
Translational22123654083325083121147162194216231269308340356
Medicine2012;258336540835489129144176191229264298333364394407
10:30053654083346679
14.30993654083346578
23.21403753085367083
Bujas22393754083357184114139
T,239437540833239
Marusic244937540835585104140164177207
Z,267237540833849
Peric2737375408335668699129
Balja2882375408335667993123
M,302137540835465
Mijic3102375408355688194124
A,324237540834153
Kruslin33113754083355592116129142178
B,350537540833545
Tomas356737540833264120150175
D.375837540834554
MAGE-A3/4andNY-ESO-1antigensexpression21403854083549313416518422225527730634638241847150552055258462965067971975477378682285589091495798610231042107310981122113411701206
inmetastaticesophagealsquamouscellcarcinoma.EurJHistochem.2011;55(1):e7.3359385408310451111431631932182382692883013303733974332140395408338741041401732022152492853203504054414765005395705845966356666847137267617968528828939339679861018107010831106112711611191122712591314132513671399142814531459150115311546157515871597163916691673
24.3940553085367085
Kageyama40385540833568107141172205262294
S.43455540833245
Adoptive44035540834078116155177192224258
Transfer4674554083324982119145165199220
of49075540833756
MAGE-A449755540835596138171192233268
T-cell5255554083335184117133148
Receptor541555408335701021361743940654083215778
Gene-Transduced40306540834377114148170199216248284310348384415448486
Lymphocytes45286540833158116154191228260292316349375
in49176540831249
Patients4978654083346586101134171192219
with5208654083506587124
Recurrent53436540833569101137158179212249269
Esophageal3940754083336098138176208247282314329
Cancer.42827540834073111143177198208
Clin4503754083405570108
Cancer46247540834073111143176197
Res.4835754083357097110
2015;49587540833468100130141
21(10):5112754083346580112143162173
2268–2277.52987540833569103138175207241274309315
25.3940853085367287
Pardoll4041854083356788126164180195
DM.425085408345100114
The43788540833271106
blockade4498854083395493125155189228263
of47748540833757
immune48468540831370128166204239
checkpoints50988540833270105137167208247262300321349
in54628540831351
cancer5526854083326539409540833870103125
immunotherapy.40809540831775133171209247269307342363396435467477
Nature4575954083457799137158192
Reviews.47829540833973106122156207234248
Cancer.50489540834073111143177198208
March52759540835487108139177
2012;54679540833771103133145
12(4):39401054083346481114132144
252–264.409910540833469102136168202238251
26.39401153085367187
Doi40461154083458499
T,416111540833645
Piha-Paul42211154083395492124146183215253268
SA,45041154083377892
Jalal46111154083286076108123
SI,47491154083375164
Mai-Dang483211540835587102124171204242281
H,513211540834457
Saraf52041154083366990123142
S,536211540833649
Koshiji542611540833976103141156171186
M.394012540835468
Updated402112540834483123155176210250
results42861254083185279116132154182
for44831254083165475
the45731254083205893
advanced467912540833271103136174206240279
esophageal49711254083346199139177210249284315331
carcinoma53151254083316485116131169207265298
cohort394013540833168107145167191
of415013540833756
the42221354083246398
phase433813540833977110136171
Ib452413540831857
KEYNOTE-028459713540833872109155203235269291328361394
study50071354083295290129161
of518713540833756
pembrolizumab526213540833874132171193230246261290328394014540835790129
(MK-3475).408414540831770106126158193225258277288
Journal43871454083226098119158190206
of460614540833756
Clinical46761454083395570108123155187203
Oncology489214540834786118155171209248280
34,51851454083357082
no.52801454083387689
4_suppl53821454083347098136175214230
(February39401554083195185124146184217238272
14227155408334
2016)427715540833468100131149
7–7.44411554083346798105
27.39401653085367180
Bang403516540833568106145
YJ,41961654083355668
Cho427916540834078116
JY,44111654083246068
Kim449416540833552109
YH,46191654083358093
Kim472716540833552109
JW,48521654083248292
Di495916540834661
Bartolomeo50351654083366990115152167206264299338
M,538816540835468
Ajani54711654083415789127142
JA,39401754083246478
Yamaguchi403017540833564122154193230262299314
K,435717540833549
Balogh44191754083356883121160198
A,462917540834155
Sanchez469717540833264102134172206236
T,494517540833341
Moehler499917540835492128165181215236
M.524817540835468
Efficacy5328175408333506886118150182215
of555617540833756
Sequential394018540833268107145179218239254286302
Ipilimumab4257185408317567287102160197255287327
Monotherapy460118540835593131170192230265286319358389
versus50061854083346889116153180
Best52031854083367198121
Supportive533918540833572111151190211236251394019540833266
Care40211954083407394128
for41641954083195678
Unresectable425719540834482103137164199231256288328343378
Locally465119540833168101134149164196
Advanced/Metastatic486219540834180112145183215249289315370405427460486509542564579611
Gastric5488195408344771033940205408322435991
or404620540834163
Gastroesophageal412820540834376102126147184220247285325363395434469501517
Junction466020540832866104136160175213252
Cancer.493120540834072110143176198208
Clin51582054083405570108
Cancer528520540834073111143177198
Res.549820540833974101115
2017;394021540833468100129139
23(19):40952154083346887118148166178
5671–5678.428921540833468101133166200234267301314
28.39402253085367288
Janjigian40432254083225492107122161176207245
YY,43012254083357482
Bendell439622540833570108147182197212
J,462322540832234
Calvo46702254083407288120158
E,484022540833346
Kim489922540833551108
JW,50232254083217989
Ascierto512522540834169101116150171196233
PA,53702254083367387
Sharma547022540833270102123394023540835790
P,404623540833540
Ott41022354083477095
PA,42132354083357286
Peltola43162354083356884106143159191
K,452323540833550
Jaeger45882354083255792132167188
D,479223540834556
Evans48642354083336598136162
J,504123540832537
de509523540833873
Braud51842354083355689127166
F,536523540833440
Chau542123540834077110147
I,558423540831528
Harbison39402454083447698137153179217256
CT,42122454083397584
Dorange431224540834584105138176215250
C,457824540834053
Tschaika46472454083335487125157172202236
M,489924540835467
Le498224540833266
DT.50642454083457786
CheckMate-032516624540834078113146176232265287320344381414446
Study:39402554083325391130161175
Efficacy4128255408332506785117150182215
and435625540833169108
Safety44772554083326583118140173
of466325540833756
Nivolumab47322554083456092129145182240272311
and505525540833270109
Nivolumab51762554083456092130145183240272311
Plus55002554083354987113
Ipilimumab394026540831554698499156194251283322
in427826540831250
Patients43402654083356789104138176198225
With45782654083577395133
Metastatic472426540835489111144170193226248263294
Esophagogastric50312654083336098138176208247285324356383406427442474
Cancer.551826540834072394027540833870103125135
J4090275408324
Clin41302754083405570108
Oncol.425327540834786118155171184
2018;445227540833468100131143
36(28):46102754083356988122156174186
2836–2844.481127540833468102136174206239276313325
29.39402853085367285
Eichelbaum40412854083365183121156172211244281339
M,439928540835468
Ingelman-Sundberg44822854083185695130146204236274296328365403442481517538576
M,507728540835468
Evans516028540833668101139165
WE.534428540835791104
Pharmacogenomics546428540833876108129394029540835788120156195229266304361376407434
and438729540833168107
Individualized45082954083125088103135150188225256271286314348386
Drug490729540834566103142
Therapy.506129540833271105126158196227236
Annual531029540834078115152183198
Review55212954083356939403054083324782133
of408930540833756
Medicine,416030540835590130145177192230265277
2006;445230540833468104140152
57(1):46203054083346783115130141
119–137.47773054083346292129160190222228
30.39403153085367287
Yao404031540833564103
Y,415531540833644
He421231540834478
Y,430331540833544
Han435931540834477115
X,448631540833952
Ji455331540832237
C,460331540833952
Hu466831540834482
B.476331540833548
Clinical48243154083405570107122154187202
research50423154083185279113145166197235
of529031540833756
individualized536131540831350891041371531912293940325408332476291124164
therapy41193254083195792113146185216
in435032540831250
advanced441332540833170103135173205238278
esophageal47043254083336098137176208247281313328
cancer504532540833164102133167188
based52463254083387197132172
on543032540833776
the55213254083195792
ERCC1394033540833368109147179
C8092A413433540834075110145178220
genotype.437033540833873111149171205245280292
Oncology467833540834785118154170209248280
Letters.49733354083326688113146168195208
2018.519733540833468100131144
31.39403453085366981
Künzli403634540833977115144160175
HT,42303454083447887
van433334540833568106
Berge44553454083397496134169
Henegouwen464334540834479117152192230268319354392
MI,50543454083557083
Gisbertz51573454083435985124159181205236
SS,54083454083376982
van550534540833669107
Esser39403554083336087122143
S,409835540833750
et416335540833861
al.42393554083365164
Pilot-study43183554083405470108130149176199237276308
on464235540834180
the47373554083266499
feasibility48513554083235789116130170185200215238271
of513835540834161
sentinel521435540833065103125140178213229
node545835540834280119154
navigation394036540833870101117156188210225263302
surgery42573654083306788126161182216
in448936540831856
combination456036540833572130169185223255277292330368
with49473654083516689127
thoracolaparoscopic50893654083256410212315618922624127431334636740443146350039403754083405689
lymphadenectomy404537540832154115155195229269305345381415440478539570
without46373754083526892131171210234
esophagectomy488737540834068108149189222263299333358396457488
in539237540832059
early54673754083417496113145
esophageal39403854083346199139177209248283315330
adenocarcinoma428338540833271106144183215248269300315353391450482
patients.47783854083397293109143181203231244
Dis50353854083466187
Esophagus.51353854083336099138177209248286312325
2017;547338540833569100130139
30(11):39403954083346988120148162174
1–8.412939540833467103117